Progresses on active targeting liposome drug delivery systems for tumor therapy / 生物医学工程学杂志
Journal of Biomedical Engineering
;
(6): 633-638, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-939632
ABSTRACT
Liposome is an ideal drug carrier with many advantages such as excellent biocompatibility, non-immunogenicity, and easy functionalization, and has been used for the clinical treatment of many diseases including tumors. For the treatment of tumors, liposome has some passive targeting capability, but the passive targeting effect alone is very limited in improving the drug enrichment in tumor tissues, and active targeting is an effective strategy to improve the drug enrichment. Therefore, active targeting liposome drug-carriers have been extensively studied for decades. In this paper, we review the research progresses on active targeting liposome drug-carriers based on the specific binding of the carriers to the surface of tumor cells, and summarize the opportunities, challenges and future prospects in this field.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Drug Carriers
/
Drug Delivery Systems
/
Liposomes
/
Neoplasms
Limits:
Humans
Language:
Chinese
Journal:
Journal of Biomedical Engineering
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS